How Surveillance Program Can Make a Difference When Breast Cancer Risk is High

Mother and adult daughter.
Print icon

One important way women at increased risk for breast cancer can monitor their health is by participating in Hartford HealthCare’s Breast Cancer Risk Assessment and Surveillance Program.

A variety of factors can may contribute to a woman’s risk of developing breast cancer, including:

  • A strong family history of breast cancer.
  • A benign breast biopsy with pathology that includes atypical cells.
  • Genetic predisposition to breast cancer such as a variant in BRCA 1 or 2 genes.
  • A history of chest wall radiation before the age of 30.
  • Increased risk scores based on commonly used models that take into account the woman’s health history and other factors to predict the lifetime risk of breast cancer.

“This is a multi-site program comprised of breast cancer specialists throughout the Hartford HealthCare Cancer Institute — both oncology and surgical team members — who are invested in providing women with a personalized breast cancer risk assessment,” said Dr. Daniel Morganstern, a breast medical oncologist who serves as physician leader of the program and works in close coordination with Dr. Patricia DeFusco, director of the Cancer Institute’s Breast Program. Dr. Morganstern also oversees the Cancer Genetics Program.

Identifying women at increased risk for breast cancer, Dr. Morgenstern said, can lead to tailored approaches to breast cancer screening beyond standard mammography, including education about lifestyle changes that might help lower a woman’s risk and, in some cases, procedures or medications that can lower the risk of breast cancer.

Patients at the Breast Cancer Risk Assessment and Surveillance Program meet with a physician or specially-trained nurse practitioner to have a clinical breast exam and review various factors, including:

  • Family history.
  • Reproductive history.
  • Hormonal exposures such as use of hormonal replacement therapy and birth control.
  • Breast imaging.

“Patients will leave with a more precise understanding of their actual risk for developing cancer, be it average, increased or decreased as compared with the ‘average’ woman in their age group,” Dr. Morganstern said. “They will also leave with a plan of action to ensure early detection and decreased risk.

“In some cases, women will learn that their risk is lower than they had previously understood, which is a good thing, too!”

The goal of the Breast Cancer Risk Assessment and Surveillance Program is to help women with concerns about their breast cancer risk understand their situation, monitor their breast health and, ultimately, drive down the rates of breast cancer, which currently affects one in eight women, he added.

“The other goal is to ensure that if a breast cancer is diagnosed, despite enhanced surveillance and preventive measures, that it is diagnosed in its most early and curable stages,” Dr. Morganstern said. “Early diagnosis also helps to minimize the extent of surgical and medical treatments that are necessary, making it easier to recover after this often life-changing diagnosis.”

The program, he said, also works to connect women who are interested in “partnering with us to advance the prevention field” to clinical trials of breast cancer preventive strategies and novel imaging approaches.

“We are working to make this program standardized and widely available through the breast cancer specialists affiliated with the Hartford HealthCare Cancer Institute,” Dr. Morgenstern said.

For more information on theHartford HealthCare Cancer Institute Breast Cancer Risk Assessment and Surveillance Program, call 855.255.6181.


What's New

Healthy Diet

Cancer Survivors: Find The Power of a Healthy Diet

By Diane Avino Dietitian Gray Cancer Center Hartford HealthCare Cancer Institute at Hartford Hospital Eating well is important during all stages of life, but it’s particularly important for cancer survivorship. Adequate nutrition is a crucial part of staying well through cancer treatments as well as promoting your long-term health. Eating...

Immunotherapy

As Cancer Treatment Evolves, a Focus on Reducing Side Effects

By Dr. Omar Eton Melanoma DMT Lead Hartford HealthCare Cancer Institute Over the past two decades, there has been great progress in understanding the relationship between cancer and the defenses a patient can muster against it. This led to a Nobel Prize for James P. Allison and Tasuku Honjo in...

Stomach Cancer

Stomach Cancer: Signs You Shouldn’t Ignore

By Dr. Bret Schipper Chief of Surgical Oncology The Hospital of Central Connecticut and MidState Medical Center Stomach, or gastric, cancer in the United States is somewhat rare, but it’s important to know the signs and symptoms. According to the American Cancer Society, about 27,500 cases of stomach cancer will...

Dr. Bret Schipper

Dr. Bret Schipper, New Surgical Oncology Chief, Starts Seeing Patients

The Hartford HealthCare Cancer Institute has announced the appointment of Dr. Bret Schipper as chief of surgical oncology at Hartford Hospital and director of oncologic surgery for the entire Cancer Institute. Dr. Schipper’s areas of interest include hepatobiliary surgery, both benign and malignant; minimally-invasive robotic surgery; soft tissue (melanoma/sarcoma) and gastric...

Senior man giving wife a kiss

Why ‘Hot Chemo’ Can Be More Effective Than IV Against Cancer

While traditional chemotherapy drips intravenously into the body to circulate and attack deadly cancer cells, a faster, a more effective way of helping people with some cancers is now available at the Hartford HealthCare Cancer Institute. Called Hyperthermic Intraperitoneal Chemotherapy (HIPEC), the treatment is designed for people with cancers of...

Pancreatic Cancer

Where a Radiation Oncologist Fits in Your Pancreatic Cancer Treatment

Treating hepatobiliary cancer involves getting the most powerful treatment directly to the source of the disease, which is where the skill of a radiation oncologist often comes in. Dr. Timothy Boyd, a radiation oncologist with Hartford Hospital and part of the Hartford HealthCare Cancer Institute’s team approach to treating pancreatic...

Chemo

Targeted Chemo Treatments Promising for HPB Patients

Everyone knows the connection between chemotherapy and cancer. It’s treatment and disease. With pancreatic cancer, maybe more than in other cancers, chemotherapy constitutes an integral part of the treatment. Medical oncologists oversee the use of chemo and other systemic treatments in patients with cancer, according to Dr. Rawad Elias, a...